コグニティブ診断の世界市場レポート 2025年

コグニティブ診断市場規模は、今後数年で飛躍的な成長が見込まれます。2029年にはCAGR22.9％で142億5,000万米ドルに成長します。予測期間の成長は、デジタルヘルス技術の採用拡大、早期診断と予防診断への注目の高まり、神経変性疾患の有病率の上昇、先進バイオマーカーの開発、遠隔医療と遠隔モニタリングの拡大、研究開発投資の強化、ヘルスケア支出の増加に起因します。予測期間における主な動向としては、AIとビッグデータ解析の統合、デジタル認知評価ツールの拡大、認知モニタリング用ウェアラブルデバイスの利用拡大、バイオマーカー探索の進歩、個別化医療・精密医療の台頭、遠隔医療・遠隔診断の拡大、統合ケアソリューションの開発、ハイテク企業とヘルスケアプロバイダーとの連携強化などが挙げられます。

神経疾患の有病率の増加は、今後のコグニティブ診断市場の成長を促進すると予想されます。神経疾患とは、脳、脊髄、神経系に影響を及ぼし、認知機能の低下、運動機能障害、感覚異常などの症状を引き起こす疾患です。これらの疾患の増加は、アルツハイマー病やパーキンソン病のような加齢に関連した疾患の発生率の増加が主な原因です。さらに、遺伝的要因、環境毒素、ストレス、食生活の乱れ、座りっぱなしのライフスタイルなども、神経疾患の有病率の上昇に寄与しています。コグニティブ診断は、認知機能障害の評価、検出、モニタリングにおいて重要な役割を果たし、アルツハイマー病やパーキンソン病などの疾患の早期診断と管理を助けます。例えば、2024年5月、アルツハイマー病のケアと研究に焦点を当てた米国の非営利団体であるアルツハイマー病協会（Alzheimer's Association）は、アルツハイマー型認知症と診断された65歳以上の米国人の数が増加し、2022年の650万人から2024年には690万人になると推定されると報告しました。このように、神経疾患の罹患率の上昇がコグニティブ診断市場の成長を促進しています。

コグニティブ診断市場の主要企業は、神経心理学的検査プラットフォームなどの診断ツールの技術革新を通じて、リアルタイムの認知健康洞察を進めています。これらのプラットフォームは、記憶力、注意力、問題解決能力などの標準化されたテストを通じて認知機能を評価するために使用される専門的なデジタルツールです。例えば、2024年4月、米国を拠点とするデジタルヘルス企業BrainCheck Inc.は、米国神経学会（AAN）年次総会でデジタル認知評価プラットフォームを発表しました。このプラットフォームは、認知機能のスクリーニング、評価、ケア計画のための先進的なツールを備えており、Assess（評価）、Screen（スクリーニング）、Plan（計画）の各モジュールを含みます。同プラットフォームは、正確さと使いやすさを保証するモバイル・デジタル技術により、認知機能を管理する最新のソリューションを臨床医に提供するもので、エビデンスに基づく詳細な推奨と包括的なケアプランニングを通じて、ケアの効率と質の向上を目指しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界コグニティブ診断 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のコグニティブ診断市場：成長率分析
• 世界のコグニティブ診断市場の実績：規模と成長, 2019-2024
• 世界のコグニティブ診断市場の予測：規模と成長, 2024-2029, 2034F
• 世界コグニティブ診断総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のコグニティブ診断市場診断別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 脳画像検査
• 臨床検査
• 精神状態検査
• 迅速な家庭用スクリーニング検査
• 神経心理学的検査
• 脳波（EEG）
• 認知機能と行動テスト
• 神経精神医学的評価質問票（NPI-Q）
• 世界のコグニティブ診断市場：適応症別、実績と予測, 2019-2024, 2024-2029F, 2034F
• アルツハイマー病
• 注意欠陥多動性障害
• 痴呆
• てんかん関連認知機能障害
• 軽度認知障害
• パーキンソン病関連認知機能障害
• 脳卒中関連認知機能障害
• 外傷性脳損傷
• その他の適応症
• 世界のコグニティブ診断市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 神経科クリニック
• 認知行動療法センター
• リハビリテーションセンター
• 学術研究機関
• 診断画像センター
• 在宅ケア設定
• 世界のコグニティブ診断市場脳画像検査の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 磁気共鳴画像法（MRI）
• 陽電子放出断層撮影（PET）
• コンピュータ断層撮影（CT）スキャン
• 機能的MRI（fMRI）
• 単一光子放出コンピュータ断層撮影（SPECT）
• 脳磁図（MEG）
• 世界のコグニティブ診断市場、臨床検査の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 認知障害の血液バイオマーカー
• 認知障害の遺伝子検査
• 脳脊髄液（CSF）バイオマーカー検査
• ホルモンおよび代謝検査
• アルツハイマー病の遺伝子配列解析
• 世界のコグニティブ診断市場精神状態検査の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ミニメンタルステート検査（MMSE）
• モントリオール認知評価（MoCA）
• セントルイス大学精神状態（SLUMS）検査
• 認知評価スクリーニングツール
• 世界のコグニティブ診断市場、迅速家庭用スクリーニング検査の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 自己管理型認知テスト
• モバイルアプリベースの認知スクリーニング
• 自宅でできる記憶力とメンタルヘルスのテスト
• 世界のコグニティブ診断市場神経心理学的検査の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 認知行動評価バッテリー
• 注意力と記憶機能テスト
• 実行機能と問題解決能力テスト
• 言語および視覚学習テスト
• 世界のコグニティブ診断市場、脳波（EEG）のサブセグメンテーション（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• 認知障害における安静時脳波
• 事象関連電位（ERP）検査
• 脳マッピングのための定量的脳波（QEEG）
• 認知障害に対する長期脳波モニタリング
• 世界のコグニティブ診断市場認知機能および行動テストの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 記憶機能検査
• 注意力と集中力のテスト
• 言語とコミュニケーションのテスト
• 気分と行動の評価
• 世界のコグニティブ診断市場神経精神医学的評価質問票（NPI-Q）のサブセグメンテーション（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• 認知症スクリーニングのためのNPI-Q
• 認知症の行動心理症状（BPSD）評価
• アルツハイマー病およびその他の認知障害に対するNPI-Q
• 臨床現場向けNPI-Q短縮版

第7章 地域別・国別分析

• 世界のコグニティブ診断市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のコグニティブ診断市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• コグニティブ診断市場：競合情勢
• コグニティブ診断市場：企業プロファイル
  • Cogstate Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Viz.ai Overview, Products and Services, Strategy and Financial Analysis
  • Redcliffe Labs Overview, Products and Services, Strategy and Financial Analysis
  • Mind Maze Overview, Products and Services, Strategy and Financial Analysis
  • Neurocare Group AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Pathway Genomics
• Diadem srl
• Cambridge Cognition Ltd.
• Posit Science Corporation
• Anderson Diagnostics & Labs.
• Altoida AG
• BrainScope Company Inc.
• Neurotrack Technologies Inc.
• Cognetivity Neurosciences Ltd.
• BrainCheck
• Cyclops MedTech Pvt Ltd
• Twill Inc.
• CN Diagnostics
• Savonix Inc.
• Cognivue Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• コグニティブ診断市場2029：新たな機会を提供する国
• コグニティブ診断市場2029：新たな機会を提供するセグメント
• コグニティブ診断市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Cognitive diagnostics involves assessing and evaluating an individual's cognitive functions to diagnose and understand cognitive disorders or impairments. This field focuses on identifying issues related to memory, attention, language, problem-solving, and other cognitive abilities. It employs a range of methods and tools to analyze cognitive performance and detect conditions such as dementia, Alzheimer's disease, traumatic brain injury, and other cognitive impairments.

The primary types of cognitive diagnostics include brain imaging tests, laboratory tests, mental status assessments, rapid home screening tests, neuropsychological testing, electroencephalograms (EEG), cognitive function and behavioral tests, and the neuropsychiatric inventory questionnaire (NPI-Q). Brain imaging tests, like MRI and CT scans, are used to visualize brain structure and function to identify abnormalities that might indicate cognitive disorders. Cognitive diagnostics are applied to conditions such as Alzheimer's disease, attention deficit or hyperactivity disorder, dementia, epilepsy-related cognitive dysfunction, mild cognitive impairment, Parkinson's disease-related cognitive dysfunction, stroke-related cognitive dysfunction, traumatic brain injury, and more. The end users of cognitive diagnostics include hospitals, neurology clinics, cognitive behavioral therapy centers, rehabilitation centers, academic and research institutes, diagnostic imaging centers, and home care settings.

The cognitive diagnostics market research report is one of a series of new reports from the business research company that provides cognitive diagnostics market statistics, including cognitive diagnostics industry global market size, regional shares, competitors with an cognitive diagnostics market share, detailed cognitive diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the cognitive diagnostics industry. This cognitive diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cognitive diagnostics market size has grown exponentially in recent years. It will grow from $5.07 $ billion in 2024 to $6.25 $ billion in 2025 at a compound annual growth rate (CAGR) of 23.1%. The growth in the historic period can be attributed to increased prevalence of cognitive disorders, advances in neuroimaging technology, growing awareness of early diagnosis, a rising geriatric population, government funding for research, expanding clinical trials, and increased demand for personalized medicine.

The cognitive diagnostics market size is expected to see exponential growth in the next few years. It will grow to $14.25 $ billion in 2029 at a compound annual growth rate (CAGR) of 22.9%. The growth in the forecast period can be attributed to growing adoption of digital health technologies, increased focus on early and preventive diagnostics, rising prevalence of neurodegenerative diseases, development of advanced biomarkers, expansion of telemedicine and remote monitoring, enhanced research and development investments, and growing healthcare expenditure. Major trends in the forecast period include integration of AI and big data analytics, expansion of digital cognitive assessment tools, increased use of wearable devices for cognitive monitoring, advances in biomarker discovery, rise in personalized and precision medicine, growth of remote and telehealth diagnostics, development of integrated care solutions, and increased collaboration between tech companies and healthcare providers.

The increasing prevalence of neurological disorders is anticipated to drive the growth of the cognitive diagnostics market in the future. Neurological disorders are conditions that affect the brain, spinal cord, and nervous system, leading to symptoms such as cognitive decline, motor dysfunction, and sensory abnormalities. The rise in these disorders is largely due to the growing incidence of age-related conditions like Alzheimer's and Parkinson's disease. Additionally, hereditary factors, environmental toxins, stress, poor diets, and sedentary lifestyles all contribute to the growing prevalence of neurological disorders. Cognitive diagnostics play a crucial role in evaluating, detecting, and monitoring cognitive impairments, which aids in the early diagnosis and management of diseases such as Alzheimer's and Parkinson's. For example, in May 2024, the Alzheimer's Association, a U.S.-based nonprofit organization focused on Alzheimer's care and research, reported an increase in the number of Americans aged 65 and older diagnosed with Alzheimer's dementia, rising from 6.5 million in 2022 to an estimated 6.9 million in 2024. Thus, the rising incidence of neurological disorders is driving the growth of the cognitive diagnostics market.

Key companies in the cognitive diagnostics market are advancing real-time cognitive health insights through technological innovations in diagnostic tools, such as neuropsychological testing platforms. These platforms are specialized digital tools used to assess cognitive functions through standardized tests, including memory, attention, and problem-solving skills. For instance, in April 2024, BrainCheck Inc., a U.S.-based digital health company, introduced its digital cognitive assessment platform at the American Academy of Neurology (AAN) Annual Meeting. The platform features advanced tools for cognitive screening, assessment, and care planning, including modules for Assess, Screen, and Plan. It offers clinicians a modern solution to manage cognitive health with mobile, digital technology that ensures accuracy and ease of use, aiming to improve the efficiency and quality of care through detailed, evidence-based recommendations and comprehensive care planning.

In July 2024, Lantheus Holdings, Inc., a U.S.-based radiopharmaceutical company, acquired Meilleur Technologies Inc. for an undisclosed amount. This acquisition is intended to strengthen Lantheus's portfolio in Alzheimer's disease diagnostics by integrating Meilleur's NAV-4694, which detects beta-amyloid plaques, with Lantheus's existing PET agent MK-6240 for tau tangles. This combination allows Lantheus to provide a comprehensive diagnostic solution for Alzheimer's, supporting both early detection and the evaluation of disease-modifying treatments. Meilleur Technologies Inc. is a U.S.-based company specializing in radiopharmaceutical diagnostics for cognitive conditions.

Major companies operating in the cognitive diagnostics market are Cogstate Ltd., Viz.ai, Redcliffe Labs, Mind Maze, Neurocare Group AG, Pathway Genomics, Diadem srl, Cambridge Cognition Ltd., Posit Science Corporation, Anderson Diagnostics & Labs. , Altoida AG, BrainScope Company Inc., Neurotrack Technologies Inc., Cognetivity Neurosciences Ltd., BrainCheck, Cyclops MedTech Pvt Ltd, Twill Inc., CN Diagnostics, Savonix Inc., Cognivue Inc., NeuroCog Trials, Pearson Clinical, Re,Cognition Health, CogniSense, The Neuropsychology Consultants

North America was the largest region in the cognitive diagnostics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cognitive diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cognitive diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cognitive diagnostics market consists of revenues earned by entities by providing services such as consultation services, rehabilitation services, and therapy services. The market value includes the value of related goods sold by the service provider or included within the service offering. The cognitive diagnostics market also includes sales of cognitive assessment software, neuropsychological testing kits, smartwatches and wearables with cognitive monitoring capabilities, and brain training software and apps. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cognitive Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cognitive diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cognitive diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cognitive diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Diagnosis: Brain Imaging Tests; Laboratory Testing; Mental Status Testing; Rapid Home Screening Tests; Neuropsychological Testing; Electroencephalogram (EEG); Cognitive Function And Behavioral Tests; Neuropsychiatric Inventory Questionnaire (NPI-Q)
• 2) By Indication: Alzheimer's Disease; Attention Deficit Or Hyperactivity Disorder; Dementia; Epilepsy-Related Cognitive Dysfunction; Mild Cognitive Impairment; Parkinson's Disease-Related Cognitive Dysfunction; Stroke-Related Cognitive Dysfunction; Traumatic Brain Injury; Other Indications
• 3) By End User: Hospitals; Neurology Clinics; Cognitive Behavioral Therapy Centers; Rehabilitation Centers; Academic And Research Institutes; Diagnostic Imaging Centers; Home Care Settings
• Subsegments:
• 1) By Brain Imaging Tests: Magnetic Resonance Imaging (MRI); Positron Emission Tomography (PET); Computed Tomography (CT) Scans; Functional MRI (fMRI); Single-Photon Emission Computed Tomography (SPECT); Magnetoencephalography (MEG)
• 2) By Laboratory Testing: Blood Biomarkers for Cognitive Disorders; Genetic Testing for Cognitive Impairment; CSF (Cerebrospinal Fluid) Biomarker Tests; Hormonal and Metabolic Testing; Genetic Sequencing for Alzheimer's Disease
• 3) By Mental Status Testing: Mini-Mental State Examination (MMSE); Montreal Cognitive Assessment (MoCA); Saint Louis University Mental Status (SLUMS) Exam; Cognitive Assessment Screening Tools
• 4) By Rapid Home Screening Tests: Self-Administered Cognitive Tests; Mobile App-Based Cognitive Screening; At-Home Memory and Mental Health Tests
• 5) By Neuropsychological Testing: Cognitive and Behavioral Assessment Batteries; Attention and Memory Function Tests; Executive Function and Problem-Solving Tests; Verbal and Visual Learning Tests
• 6) By Electroencephalogram (EEG): Resting-State EEG for Cognitive Disorders; Event-Related Potential (ERP) Testing; Quantitative EEG (QEEG) for Brain Mapping; Long-Term EEG Monitoring for Cognitive Disorders
• 7) By Cognitive Function and Behavioral Tests: Memory Function Tests; Attention and Concentration Tests; Language and Communication Tests; Mood and Behavior Assessments
• 8) By Neuropsychiatric Inventory Questionnaire (NPI-Q): NPI-Q for Dementia Screening; Behavioral and Psychological Symptoms of Dementia (BPSD) Assessment; NPI-Q for Alzheimer's Disease and Other Cognitive Disorders; Shortened Versions of NPI-Q for Clinical Settings.
• Companies Mentioned: Cogstate Ltd.; Viz.ai; Redcliffe Labs; Mind Maze; Neurocare Group AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cognitive Diagnostics Market Characteristics

3. Cognitive Diagnostics Market Trends And Strategies

4. Cognitive Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Cognitive Diagnostics Growth Analysis And Strategic Analysis Framework

• 5.1. Global Cognitive Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Cognitive Diagnostics Market Growth Rate Analysis
• 5.4. Global Cognitive Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Cognitive Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Cognitive Diagnostics Total Addressable Market (TAM)

6. Cognitive Diagnostics Market Segmentation

• 6.1. Global Cognitive Diagnostics Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Brain Imaging Tests
• Laboratory Testing
• Mental Status Testing
• Rapid Home Screening Tests
• Neuropsychological Testing
• Electroencephalogram (EEG)
• Cognitive Function And Behavioral Tests
• Neuropsychiatric Inventory Questionnaire (NPI-Q)
• 6.2. Global Cognitive Diagnostics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Alzheimer's Disease
• Attention Deficit Or Hyperactivity Disorder
• Dementia
• Epilepsy-Related Cognitive Dysfunction
• Mild Cognitive Impairment
• Parkinson's Disease-Related Cognitive Dysfunction
• Stroke-Related Cognitive Dysfunction
• Traumatic Brain Injury
• Other Indications
• 6.3. Global Cognitive Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Neurology Clinics
• Cognitive Behavioral Therapy Centers
• Rehabilitation Centers
• Academic And Research Institutes
• Diagnostic Imaging Centers
• Home Care Settings
• 6.4. Global Cognitive Diagnostics Market, Sub-Segmentation Of Brain Imaging Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Magnetic Resonance Imaging (MRI)
• Positron Emission Tomography (PET)
• Computed Tomography (CT) Scans
• Functional MRI (fMRI)
• Single-Photon Emission Computed Tomography (SPECT)
• Magnetoencephalography (MEG)
• 6.5. Global Cognitive Diagnostics Market, Sub-Segmentation Of Laboratory Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Blood Biomarkers for Cognitive Disorders
• Genetic Testing for Cognitive Impairment
• CSF (Cerebrospinal Fluid) Biomarker Tests
• Hormonal and Metabolic Testing
• Genetic Sequencing for Alzheimer's Disease
• 6.6. Global Cognitive Diagnostics Market, Sub-Segmentation Of Mental Status Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Mini-Mental State Examination (MMSE)
• Montreal Cognitive Assessment (MoCA)
• Saint Louis University Mental Status (SLUMS) Exam
• Cognitive Assessment Screening Tools
• 6.7. Global Cognitive Diagnostics Market, Sub-Segmentation Of Rapid Home Screening Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Self-Administered Cognitive Tests
• Mobile App-Based Cognitive Screening
• At-Home Memory and Mental Health Tests
• 6.8. Global Cognitive Diagnostics Market, Sub-Segmentation Of Neuropsychological Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cognitive and Behavioral Assessment Batteries
• Attention and Memory Function Tests
• Executive Function and Problem-Solving Tests
• Verbal and Visual Learning Tests
• 6.9. Global Cognitive Diagnostics Market, Sub-Segmentation Of Electroencephalogram (EEG), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Resting-State EEG for Cognitive Disorders
• Event-Related Potential (ERP) Testing
• Quantitative EEG (QEEG) for Brain Mapping
• Long-Term EEG Monitoring for Cognitive Disorders
• 6.10. Global Cognitive Diagnostics Market, Sub-Segmentation Of Cognitive Function and Behavioral Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Memory Function Tests
• Attention and Concentration Tests
• Language and Communication Tests
• Mood and Behavior Assessments
• 6.11. Global Cognitive Diagnostics Market, Sub-Segmentation Of Neuropsychiatric Inventory Questionnaire (NPI-Q), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• NPI-Q for Dementia Screening
• Behavioral and Psychological Symptoms of Dementia (BPSD) Assessment
• NPI-Q for Alzheimer's Disease and Other Cognitive Disorders
• Shortened Versions of NPI-Q for Clinical Settings

7. Cognitive Diagnostics Market Regional And Country Analysis

• 7.1. Global Cognitive Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Cognitive Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cognitive Diagnostics Market

• 8.1. Asia-Pacific Cognitive Diagnostics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Cognitive Diagnostics Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Cognitive Diagnostics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Cognitive Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cognitive Diagnostics Market

• 9.1. China Cognitive Diagnostics Market Overview
• 9.2. China Cognitive Diagnostics Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Cognitive Diagnostics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Cognitive Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cognitive Diagnostics Market

• 10.1. India Cognitive Diagnostics Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Cognitive Diagnostics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Cognitive Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cognitive Diagnostics Market

• 11.1. Japan Cognitive Diagnostics Market Overview
• 11.2. Japan Cognitive Diagnostics Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Cognitive Diagnostics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Cognitive Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cognitive Diagnostics Market

• 12.1. Australia Cognitive Diagnostics Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Cognitive Diagnostics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Cognitive Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cognitive Diagnostics Market

• 13.1. Indonesia Cognitive Diagnostics Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Cognitive Diagnostics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Cognitive Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cognitive Diagnostics Market

• 14.1. South Korea Cognitive Diagnostics Market Overview
• 14.2. South Korea Cognitive Diagnostics Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Cognitive Diagnostics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Cognitive Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cognitive Diagnostics Market

• 15.1. Western Europe Cognitive Diagnostics Market Overview
• 15.2. Western Europe Cognitive Diagnostics Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Cognitive Diagnostics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Cognitive Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cognitive Diagnostics Market

• 16.1. UK Cognitive Diagnostics Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Cognitive Diagnostics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Cognitive Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cognitive Diagnostics Market

• 17.1. Germany Cognitive Diagnostics Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Cognitive Diagnostics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Cognitive Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cognitive Diagnostics Market

• 18.1. France Cognitive Diagnostics Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Cognitive Diagnostics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Cognitive Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cognitive Diagnostics Market

• 19.1. Italy Cognitive Diagnostics Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Cognitive Diagnostics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Cognitive Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cognitive Diagnostics Market

• 20.1. Spain Cognitive Diagnostics Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Cognitive Diagnostics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Cognitive Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cognitive Diagnostics Market

• 21.1. Eastern Europe Cognitive Diagnostics Market Overview
• 21.2. Eastern Europe Cognitive Diagnostics Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Cognitive Diagnostics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Cognitive Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cognitive Diagnostics Market

• 22.1. Russia Cognitive Diagnostics Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Cognitive Diagnostics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Cognitive Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cognitive Diagnostics Market

• 23.1. North America Cognitive Diagnostics Market Overview
• 23.2. North America Cognitive Diagnostics Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Cognitive Diagnostics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Cognitive Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cognitive Diagnostics Market

• 24.1. USA Cognitive Diagnostics Market Overview
• 24.2. USA Cognitive Diagnostics Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Cognitive Diagnostics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Cognitive Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cognitive Diagnostics Market

• 25.1. Canada Cognitive Diagnostics Market Overview
• 25.2. Canada Cognitive Diagnostics Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Cognitive Diagnostics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Cognitive Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cognitive Diagnostics Market

• 26.1. South America Cognitive Diagnostics Market Overview
• 26.2. South America Cognitive Diagnostics Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Cognitive Diagnostics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Cognitive Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cognitive Diagnostics Market

• 27.1. Brazil Cognitive Diagnostics Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Cognitive Diagnostics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Cognitive Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cognitive Diagnostics Market

• 28.1. Middle East Cognitive Diagnostics Market Overview
• 28.2. Middle East Cognitive Diagnostics Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Cognitive Diagnostics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Cognitive Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cognitive Diagnostics Market

• 29.1. Africa Cognitive Diagnostics Market Overview
• 29.2. Africa Cognitive Diagnostics Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Cognitive Diagnostics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Cognitive Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cognitive Diagnostics Market Competitive Landscape And Company Profiles

• 30.1. Cognitive Diagnostics Market Competitive Landscape
• 30.2. Cognitive Diagnostics Market Company Profiles
  • 30.2.1. Cogstate Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Viz.ai Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Redcliffe Labs Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Mind Maze Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Neurocare Group AG Overview, Products and Services, Strategy and Financial Analysis

31. Cognitive Diagnostics Market Other Major And Innovative Companies

• 31.1. Pathway Genomics
• 31.2. Diadem srl
• 31.3. Cambridge Cognition Ltd.
• 31.4. Posit Science Corporation
• 31.5. Anderson Diagnostics & Labs.
• 31.6. Altoida AG
• 31.7. BrainScope Company Inc.
• 31.8. Neurotrack Technologies Inc.
• 31.9. Cognetivity Neurosciences Ltd.
• 31.10. BrainCheck
• 31.11. Cyclops MedTech Pvt Ltd
• 31.12. Twill Inc.
• 31.13. CN Diagnostics
• 31.14. Savonix Inc.
• 31.15. Cognivue Inc.

32. Global Cognitive Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cognitive Diagnostics Market

34. Recent Developments In The Cognitive Diagnostics Market

35. Cognitive Diagnostics Market High Potential Countries, Segments and Strategies

• 35.1 Cognitive Diagnostics Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Cognitive Diagnostics Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Cognitive Diagnostics Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer